Kaskela Law LLC Announces Shareholder Investigation of Dentsply Sirona Inc. (NASDAQ: XRAY) and Encourages Long-Term XRAY Shareholders to Contact the Firm
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) --
Kaskela Law LLC announces that it is investigating Dentsply Sirona Inc. (NASDAQ: XRAY) (“Dentsply”) on behalf of the company’s long-term shareholders.
https://kaskelalaw.com/case/dentsply-sirona/
Recently an amended securities fraud complaint was filed against Dentsply on behalf of investors who purchased shares of the company’s stock between June 9, 2021 and November 13, 2022. According to the complaint, during that time period Dentsply and certain of the company’s senior executive officers materially misrepresented the company’s financial and operational results for the second half of fiscal 2021 by engaging in “channel stuffing,” “off-book arrangements,” “enhanced incentives” to end-users, and the delayed issuance of rebate checks.
The complaint further details how, through a series of partial disclosures between April 2022 and November 2022 – which included resignations, terminations, and an internal investigation by the company’s Audit and Finance Committee – investors slowly learned the truth about the company’s prior misrepresentations and suffered economic damages as a result therefrom. During that time period, the company’s stock price declined in value from approximately $48.00 per share in April 2022 to approximately $30.00 per share in November 2022.
The investigation seeks to determine whether the members of Dentsply’s board of directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct and disclosures.
Current Dentsply shareholders who purchased or acquired shares of XRAY stock prior to April 11, 2022 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 for additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or by copying and pasting the link into your browser):
https://kaskelalaw.com/case/dentsply-sirona/
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks
-
Real Estate: Performance Continues to Be Driven by Interest-Rate Movements
-
Financial Services: Sector Doing Well Heading Into Rate-Cutting Cycle
-
Energy: OPEC Faces Hard Supply Decision in Latter Half of 2024
-
This Cheap Stock Is Still a Buy Even After 50% Rally